Relative Bioavailability of Two Fixed Dose Combination Tablets of Linagliptin/Pioglitazone Compared With Single Linagliptin and Pioglitazone Tablets Administered Together to Healthy Male and Female Subjects
Clinical trial NCT02183636 · COMPLETED
Trial details
- NCT number
- NCT02183636
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2009-12-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.